Geiger Uri 4

What Happened

Uri Geiger, a member of NeuroPace's board of directors, was granted 789 shares on June 19, 2026. The award is reported as an acquisition (code A) at $15.63 per share, for a total reported value of $12,332. This was an equity award issued in lieu of quarterly retainer fees to a non-employee director.

Key Details

• Transaction date and price: 6/19/2026 — 789 shares at $15.63 each (total $12,332).
• Transaction type: Award/Grant (Form 4 code A) — not an open-market purchase or sale.
• Beneficial ownership after transaction: Not specified in the filing.
• Filing date: 6/22/2026 (filing reports the 6/19 acquisition; the filing does not indicate tardiness).
• Footnotes of note:
  • F1: Shares issued pursuant to the issuer's non-employee director compensation policy in lieu of quarterly retainer fees.
  • F2: The shares are held by Accelmed Partners II LP. Uri Geiger is managing partner of the controlling entities and has sole voting and dispositive power over those shares; Geiger is also a General Partner at Accelmed LLC.

Context

Grants to non-employee directors are routine compensation and are typically issued in lieu of cash fees; they reflect compensation policy more than a personal buy/sell decision. These shares are held through an entity (Accelmed Partners II LP) over which Geiger has control, so the filing reports beneficial control rather than direct personal custody.